Home › Cancro al fegato (carcinoma epatocellulare) › Illinois › Chicago
Studi clinici su Cancro al fegato (carcinoma epatocellulare) a Chicago, IL
16 studi su Cancro al fegato (carcinoma epatocellulare) cercano partecipanti presso sedi a Chicago e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
In reclutamentoFase 1
- Exelixis Clinical Site #26, Chicago
National Liver Cancer Screening Trial
In reclutamentoFase 4
- Northwestern University, Chicago
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
In reclutamentoFase 1/2
- Local Institution - 0107, Chicago
Defining the Ablative Dose for Y-90 TARE
In reclutamentoFase 2
- Northwestern University, Chicago
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
In reclutamentoStudio osservazionale
- RUSH University Medical Center, Chicago
- University of Chicago, Chicago
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
In reclutamentoFase 3
- Research Site, Chicago
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
In reclutamentoFase 1/2
- Lurie Children's Hospital-Chicago, Chicago
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
In reclutamentoFase 3
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer
In reclutamentoFase 2
- University of Chicago Comprehensive Cancer Center, Chicago
DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
In reclutamentoStudio osservazionale
- Rush University Medical Center, Chicago
Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer
In reclutamentoFase 1/2
- Northwestern University, Chicago
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
In reclutamentoFase 1
- Clinical Trial Site, Chicago
Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk
In reclutamentoFase 2
- Northwestern University, Chicago
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
In reclutamentoFase 4
- University of Chicago Medical Center, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, Chicago
The Dragon PLC Trial (DRAGON-PLC)
In reclutamento
- Rush University Medical Center, Chicago
Studi su Cancro al fegato (carcinoma epatocellulare) in altre città
- Houston, TX31 studi
- New York City, NY24 studi
- Dallas, TX19 studi
- Los Angeles, CA19 studi
- Boston, MA18 studi
- Cleveland, OH18 studi
- Philadelphia, PA16 studi
- Pittsburgh, PA15 studi
- San Francisco, CA14 studi
- Orange, CA14 studi
- Jacksonville, FL14 studi
- San Antonio, TX13 studi
Altri studi a Chicago
- Cancro del polmone non a piccole cellule61 studi
- Cancro al seno59 studi
- Cancro (tutti i tipi)51 studi
- Cancro metastatico45 studi
- Cancro alla prostata45 studi
- Cancro ai polmoni41 studi
- Obesità40 studi
- Cancro ovarico36 studi
- Cancro colorettale35 studi
- Ictus34 studi
- Insufficienza cardiaca31 studi
- Sovrappeso29 studi
Fonte: ClinicalTrials.gov, dati recuperati il 7 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.